BLM overexpression as a predictive biomarker for CHK1 inhibitor response in PARP inhibitor–resistant BRCA-mutant ovarian cancer
Nitasha Gupta, Tzu-Ting Huang, Jayakumar R. Nair, Daniel An, Grant Zurcher, Erika J. Lampert, Ann McCoy, Ashley Cimino-Mathews, Elizabeth M. Swisher, Marc R. Radke, Christina M Lockwood, Jonathan B. Reichel, Chih-Yuan Chiang, Kelli M. Wilson, Ken Chih-Chien Cheng, Darryl Nousome, Jung-Min Lee
doi: https://doi.org/10.1101/2022.12.02.22283037
Nitasha Gupta
1Women’s Malignancies Branch, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, Maryland, 20892, USA
Tzu-Ting Huang
1Women’s Malignancies Branch, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, Maryland, 20892, USA
Jayakumar R. Nair
1Women’s Malignancies Branch, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, Maryland, 20892, USA
Daniel An
1Women’s Malignancies Branch, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, Maryland, 20892, USA
Grant Zurcher
1Women’s Malignancies Branch, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, Maryland, 20892, USA
Erika J. Lampert
1Women’s Malignancies Branch, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, Maryland, 20892, USA
2Department of Obstetrics and Gynecology, Cleveland Clinic, Cleveland, Ohio, 44195, USA
Ann McCoy
1Women’s Malignancies Branch, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, Maryland, 20892, USA
Ashley Cimino-Mathews
3Departments of Pathology and Oncology, Johns Hopkins University School of Medicine; Baltimore, Maryland, 21231-2410, USA
Elizabeth M. Swisher
4Brotman Baty Institute of Precision Medicine, University of Washington, Seattle, Washington, 98195, USA
Marc R. Radke
4Brotman Baty Institute of Precision Medicine, University of Washington, Seattle, Washington, 98195, USA
Christina M Lockwood
4Brotman Baty Institute of Precision Medicine, University of Washington, Seattle, Washington, 98195, USA
5Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, 98195, USA
Jonathan B. Reichel
4Brotman Baty Institute of Precision Medicine, University of Washington, Seattle, Washington, 98195, USA
Chih-Yuan Chiang
6National Center for Advancing Translational Sciences, NIH, Rockville, Maryland, 20892-4874, USA
Kelli M. Wilson
6National Center for Advancing Translational Sciences, NIH, Rockville, Maryland, 20892-4874, USA
Ken Chih-Chien Cheng
6National Center for Advancing Translational Sciences, NIH, Rockville, Maryland, 20892-4874, USA
Darryl Nousome
7Center for Cancer Research Collaborative Bioinformatics Resource, CCR, NCI, NIH, Bethesda, Maryland, 20892, USA
Jung-Min Lee
1Women’s Malignancies Branch, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, Maryland, 20892, USA

Data Availability
All data produced in the present work are contained in the manuscript.
Posted December 04, 2022.
BLM overexpression as a predictive biomarker for CHK1 inhibitor response in PARP inhibitor–resistant BRCA-mutant ovarian cancer
Nitasha Gupta, Tzu-Ting Huang, Jayakumar R. Nair, Daniel An, Grant Zurcher, Erika J. Lampert, Ann McCoy, Ashley Cimino-Mathews, Elizabeth M. Swisher, Marc R. Radke, Christina M Lockwood, Jonathan B. Reichel, Chih-Yuan Chiang, Kelli M. Wilson, Ken Chih-Chien Cheng, Darryl Nousome, Jung-Min Lee
medRxiv 2022.12.02.22283037; doi: https://doi.org/10.1101/2022.12.02.22283037
BLM overexpression as a predictive biomarker for CHK1 inhibitor response in PARP inhibitor–resistant BRCA-mutant ovarian cancer
Nitasha Gupta, Tzu-Ting Huang, Jayakumar R. Nair, Daniel An, Grant Zurcher, Erika J. Lampert, Ann McCoy, Ashley Cimino-Mathews, Elizabeth M. Swisher, Marc R. Radke, Christina M Lockwood, Jonathan B. Reichel, Chih-Yuan Chiang, Kelli M. Wilson, Ken Chih-Chien Cheng, Darryl Nousome, Jung-Min Lee
medRxiv 2022.12.02.22283037; doi: https://doi.org/10.1101/2022.12.02.22283037
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)